Advertising agency in FR. Official registry identity, filed financial evidence and a rounded indicative valuation range on one indexed company profile.
Historical rounded range based on the latest available public filing for fiscal year 2023. This is not a current market value or asking price.
Based on filed company accountsCreate a free account to see the detailed curve, the factors that influence it, and an indicative five-year outlook.
Free account · private workspace
You have seen the historical curve. Create a free account to explore a private five-year value scenario and the assumptions behind it.
The historical indicative range for GROUPAPHARM uses the latest available public filing and sector calibration. It is not a current market value or asking price; current owner or advisor data is needed for a full valuation.
This company is not currently listed for sale on Upswitch.
This is an estimate, not an asking price. It is based on dated public sources and is not an owner forecast, offer, investment advice, or confirmation that the company is for sale.
Request verified control to add current figures, improve the profile and manage what happens next. We verify ownership before granting access.
Operating as a advertising agency, GROUPAPHARM is registered in France. The company was founded in 2002, incorporated as a 5710.
GROUPAPHARM is listed in French National Business Register (RNE/INPI) under registry number 444194922. The public employee band is 03, a useful triage field for banks, credit analysts, and M&A acquirers. This profile consolidates official annual accounts into one indexable company dossier.
Companies in this NACE 73.11 band file annual accounts with INPI.
Across the 2015-2023 window revenue has more than doubled, moving from €130,721 to €1,762,984.
The most recent annual filing covers 2023 (period end 2023-12-31).
The historical indicative range for GROUPAPHARM is refreshed when new regulator-filed data becomes available; until then it remains a filing-year research aid, not a current market value.
Public regulator-filed figures across 6 years.
Fiscal year | Revenue | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202331 Dec 2023 | €1,762,984 | - | €1,779,370 | €1,158,488 | - |
| 202231 Dec 2022 | €1,464,404 | - | €1,339,129 | €873,732 | - |
| 202131 Dec 2021 | €1,130,987 | - | €875,396 | €557,992 | - |
| 201730 Sept 2017 | €137,102 | - | €214,987 |
GROUPAPHARM was founded in 2002 and is registered with French National Business Register (RNE/INPI), incorporated as a 5710.
GROUPAPHARM is registered under NACE 73.11: NACE 73.11. That places the business within the French cluster for this activity.
This page shows a rounded historical indicative range for GROUPAPHARM, based on the latest available public filing for fiscal year 2023. It is not a current market value, asking price, certified or statutory valuation, or financial, investment, tax or legal advice. Verify current figures before relying on it for any decision or transaction.
Company identity and public facts are reused from the official or licensed source named on this page, with its filing or update date. Upswitch estimates remain distinct from source facts and do not imply endorsement by the registry. Natural-person enterprises are excluded from public valuation pages, and public registry personal data is not used for direct marketing.
Connected to this company and want something corrected? Request a correction or removal · Privacy policy · Terms & conditions · Data sources & evidence
| €140,997 |
| - |
| 201630 Sept 2016 | €134,916 | - | €153,981 | €122,207 | - |
| 201530 Sept 2015 | €130,721 | - | €153,874 | €128,178 | - |
The most recently filed annual accounts cover fiscal year 2023 (period end 2023-12-31), publicly available via French National Business Register (RNE/INPI).
